Clinical Trial Update: Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas [Phase 1]

View source ↗

Summary

This update presents Phase 1 results from a study of REOLYSIN in patients with recurrent malignant glioma. The trial evaluates safety and preliminary efficacy i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• REOLYSIN (pelareorep)

Snippet

Sponsor: Oncolytics Biotech | Conditions: Malignant Glioma | Phase 1 | Status: COMPLETED